This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is MetLife (MET) Down 6.9% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Unveils Reinsurance Deal With Global Atlantic
by Zacks Equity Research
MetLife (MET) inscribes a deal to transfer risks related to its U.S. retail life insurance and fixed annuity products to Global Atlantic. It also announces a $1 billion buyback capacity increase.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
A Look at Insurance ETFs Post a Mixed Bag Q1
by Sweta Killa
With the Fed slowing down the pace of rate hike and expectations of a pause in further hikes coupled with mixed results of the leading players in the industry, insurance ETFs struggled to find a footing over the last month.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Company News for May 5, 2023
by Zacks Equity Research
Companies in The News Are: MET, COP, XOM, WAL
MetLife (MET) Q1 Earnings Miss on Lower Investment Income
by Zacks Equity Research
MetLife's (MET) reduced profit levels from Asia and MetLife Holdings businesses affect its first-quarter performance.
MetLife (MET) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -17.84% and 4.09%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Insurance Stocks to Post Q1 Earnings on May 3: MET, ALL & More
by Zacks Equity Research
Growing premium rates and strong retention are likely to aid insurers' Q1 results, offset by rising expenses and catastrophe losses. MET, ALL, GL, SIGI, & RDN are set to release earnings on May 3.
Zacks Industry Outlook Highlights MetLife, American International, Prudential Financial, CNO Financial and Kemper
by Zacks Equity Research
MetLife, American International, Prudential Financial, CNO Financial and Kemper have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Thriving Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, CNO and KMPR.
Will Lower Premiums Affect MetLife's (MET) Q1 Earnings?
by Zacks Equity Research
MetLife's (MET) first-quarter results are likely to reflect lower profits in Retirement & Income Solutions and MetLife Holdings businesses.
American International Group (AIG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, MetLife (MET) closed at $58.92, marking a -0.49% move from the previous day.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
MetLife (MET) closed at $60.81 in the latest trading session, marking a -1.62% move from the prior day.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
How Much Upside is Left in MetLife (MET)? Wall Street Analysts Think 34.95%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35% in MetLife (MET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.